CTOs on the Move

Intellisphere

www.hcplive.com

 
Intellisphere is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $500M-1 Billion
  • www.hcplive.com
  • 666 Plainsboro Rd
    Plainsboro, NJ USA 08536
  • Phone: 609.716.7777

Executives

Name Title Contact Details

Similar Companies

WellPath Select

WellPath Select is a Morrisville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Weber and Weber International GmbH and Co.

Weber and Weber International GmbH and Co. is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Green Roads

Shop pharmacist-formulated, lab-tested CBD oils, topicals, edibles, beverages, spa goods & more from Green Roads, a pharmacist-founded, award-winning company.

Cantel Medical

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.